Geert Vanhooren, Geert

dr. Geert Vanhooren

Neurologie

Hypothermie als behandeling voor acute ischemische beroerte

Hypothermie als behandeling voor acute ischemische beroerte

Elk jaar worden ongeveer 19.000 Belgen getroffen door een beroerte. In het merendeel van de gevallen gaat het om een ischemische beroerte. De morbiditeit, mortaliteit en het kostenplaatje zijn hoog. Naast de hemicraniëctomie op de “stroke unit” bij een maligne media-infarct en het toedienen van aspirine is de intraveneuze trombolyse een van de bewezen effectieve behandelingen in de acute fase. Helaas krijgt uiteindelijk slechts 5 tot 15% van alle patiënten intraveneus rtPA (recombinant weefselplasminogeenactivator) toegediend, gezien het beperkte tijdsvenster waarbinnen trombolyse kan worden toegepast: tot 4,5 uur na het ontstaan van de symptomen.

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Transpl Int 2011;24:e30-4.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Progressive multifocal leucoencephalopathy in liver transplant recipents: a case report and review of the literature.

Transplant International 2011;24e30-4.doi:10.1111/j.1432-2277.2010.01190x
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Are ace-inhibitors or arb’s still needed for cardiovascular prevention in high risk patients? Insights from PRoFESS and TRANSCEND.

Acta Clin Belg. 2010;65:107-114
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

B vitamins in patients with recent transient ischaemic attack or stroke in the vitamins to prevent stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial.

Lancet Neurol. 2010;9:855-865
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Angiotensin receptor blockade in acute stroke. The scandinavian candesartan acute stroke trial: Rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (nct00120003).

Int J Stroke. 2010;5:423-427
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lancet. 2010;375:1695-1703
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial.

Lancet. 2010;375:985-997
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

ESC 2010 Barcelona, Spain: Is there something wrong with Intravenous Thrombolysis in Belgium? Belgian data of the Safe Implementation of Thrombolysis in Stroke (SITS) Study.

Barcelona, Spain
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Belgian Fabry Study: Prevalence of fabry disease in a cohort of 1000 young patients with cerebrovascular disease.

Stroke. 2010;41:863-868
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Emergency administration of abciximab for treatment of patiens with acute ischemic stroke. Results of an international phase III trial : Abcimimab in emergency treatment of stroke trial (Abest-II)

Stroke. 2008;39:87-99
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Renal outcomes with telmisartan ramipril or both in people at high vascular risk (the ontarget study) : A multicentre, randomised double-blind, controlled trial.

Lancet. 2008;372:547-553
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Multivariable analysis of outcome predictors and adjustment of main outcoume results to baseline data profile in randomized controlled trials: Safe implementation of thrombolysis in stroke-monitoring study (Sits-Most).

Stroke 2008;39:3316-3322
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (Esprit): A randomised controlled trial.

Lancet Neurol 2007;6:115-124
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Sex differences in quality of life in stroke survivors: Data from the tinzaparin in acute ischaemic stroke trial (taist).

Stroke 2007;38:2960-2964
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Vitatops, the VITAmins TO Prevent Stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)

International Journal of Stroke 2007;2:144-150.
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (sits-most): an observational study.

Lancet 2007;369:275-282
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/
Toon meer